CD68 Antibody – 156Gd

Catalog: 715601                                            Clone: D4B9C                                          Isotype: Rabbit IgG
Reactivity: Human*
Storage: CD68 antibody is supplied in antibody stabilizer with 0.05% sodium azide. Store at 4°C
IHC: CD68 antibody staining of FFPE  human tonsil
MIBI: CD68 antibody staining (cyan) of FFPE human tonsil,  counterstained with histone H3 (magenta)
IHC: CD68 antibody staining of  FPE human liver
MIBI: CD68 antibody staining (cyan)  of FFPE human liver,  counterstained with histone H3 (magenta)
Background: CD68  is a marker predominantly expressed on monocytes and macrophages and is used to identify tumor-associated macrophages (TAMs). Macrophages home to specific targets in part through the interaction between CD68 and tissue- and organ-specific lectins or selectins. CD68 staining can be combined with HLA-DR to identify M1 macrophages or with CD163 to identify M2 macrophages, macrophage phenotypes with prognostic associations to outcomes in certain cancers.

Validation: Each lot of conjugated CD68 antibody is quality control tested by MIBIscope™ analysis of stained tissue microarray using the appropriate positive and negative tissue field of views and are pathologist verified.

Recommended Usage: 1 uL of CD68 antibody per 100 uL staining volume using the MIBI™ Staining Protocol.
For optimal results, antibody should be titrated for each desired application.  Suggested starting range is 1:100.

MIBI technology: Learn more about MIBI Technology, a multiplex IHC technology with unmatched sensitivity and true subcellular resolution.


  • Mei, J. et al. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget. 2016; 7(23): 34217-28.

* Conjugate tested on human tissue.

Contact Us

<p style="text-align: center; margin-top: 2em;">Let us know how we can help you.</p>

    Immuno-oncology/CancerNeuroscienceInfectious DiseaseImmunologyStem CellOther


    Please contact me. I understand that I can choose to unsubscribe at any time by e-mailing

    Contact Us

    We are using cookies on our website

    Please confirm, if you accept our tracking cookies. You can also decline the tracking and continue to visit our website without any data sent to third-party services.